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ABSTRACT The endothelium maintains a barrier between blood and tissue that becomes 
more permeable during inflammation. Membrane rafts are ordered assemblies of cholesterol, 
glycolipids, and proteins that modulate proinflammatory cell signaling and barrier function. 
In epithelial cells, the MAL family members MAL, MAL2, and myeloid-associated differentia-
tion marker (MYADM) regulate the function and dynamics of ordered membrane domains. 
We analyzed the expression of these three proteins in human endothelial cells and found that 
only MYADM is expressed. MYADM was confined in ordered domains at the plasma mem-
brane, where it partially colocalized with filamentous actin and cell–cell junctions. Small inter-
fering RNA (siRNA)-mediated MYADM knockdown increased permeability, ICAM-1 expres-
sion, and leukocyte adhesion, all of which are features of an inflammatory response. Barrier 
function decrease in MYADM-silenced cells was dependent on ICAM-1 expression. Mem-
brane domains and the underlying actin cytoskeleton can regulate each other and are con-
nected by ezrin, radixin, and moesin (ERM) proteins. In endothelial cells, MYADM knockdown 
induced ERM activation. Triple-ERM knockdown partially inhibited ICAM-1 increase induced 
by MYADM siRNA. Importantly, ERM knockdown also reduced ICAM-1 expression in response 
to the proinflammatory cytokine tumor necrosis factor-α. MYADM therefore regulates the 
connection between the plasma membrane and the cortical cytoskeleton and so can control 
the endothelial inflammatory response.
INTRODUCTION
The endothelium lines the inner side of blood vessels, forming a bar-
rier between the blood and the surrounding tissue that is essential for 
vascular homeostasis. The endothelium mediates the passage of 
small molecules and cells from the bloodstream to the tissues, with-
out compromising its integrity, in the presence of continuous osmotic 
and shear stress. The organization of the endothelial cell surface, the 
biological fence facing the vessel lumen, is thus essential for integrat-
ing signals from different sources that modulate selective permeabil-
ity, such as mechanical forces, cytokine signaling, and cell–cell inter-
actions (Millán and Ridley, 2005; Simionescu, 2007; Vandenbroucke 
et al., 2008; Reglero-Real et al., 2012).
The architecture of the endothelial surface is determined by 
the links between the plasma membrane, surface proteins, and under-
lying cytoskeleton. In the current paradigm, lipids and transmem-
brane proteins are connected to the underlying cytoskeleton like a 
Monitoring Editor
J. Silvio Gutkind
National Institutes of Health
Received: Nov 14, 2011
Revised: Nov 15, 2012
Accepted: Dec 14, 2012
This article was published online ahead of print in MBoC in Press (http://www 
.molbiolcell.org/cgi/doi/10.1091/mbc.E11-11-0914) on December 21, 2012.
*These authors contributed equally to this work.
Address correspondence to: Jaime Millán (jmillan@cbm.uam.es) or Miguel A. 
Alonso (maalonso@cbm.uam.es).
© 2013 Aranda et al. This article is distributed by The American Society for Cell 
Biology under license from the author(s). Two months after publication it is avail-
able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported 
Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).
“ASCB®,” “The American Society for Cell Biology®,” and “Molecular Biology of 
the Cell®” are registered trademarks of The American Society of Cell Biology.
Abbreviations used: BCR, B-cell receptor; DRM, detergent-resistant mem-
brane; ERM, ezrin, radixin, and moesin; FERM, 4.1 ezrin–radixin–moesin; GFP, 
green fluorescent protein; HA, hemagglutinin; HUVEC, human umbilical vein 
endothelial cell; ICAM-1, intercellular adhesion molecule-1; mAb, monoclonal 
antibody; MARVEL, MAL and related proteins for vesicle trafficking and mem-
brane link; MYADM, myeloid-associated differentiation marker; PBS, phos-
phate-buffered saline; PIP2, phosphatidylinositol 4,5-bisphosphate; PKC, 
protein kinase C; qPCR, quantitative PCR; S1P, sphingosine 1-phosphate; 
siRNA, small interfering RNA; TEER, transendothelial electrical resistance; 
TNF-α, tumor necrosis factor-α.
484 | J. F. Aranda et al. Molecular Biology of the Cell
altering barrier function through the increase of the adhesion recep-
tor ICAM-1. The rise in ICAM-1 levels is mediated by MYADM-regu-
lated activation of ERM proteins. Collectively our results strongly sug-
gest that the interaction between the plasma membrane and the 
submembrane actin cytoskeleton at the endothelial surface controls 
the inflammatory response.
RESULTS
MYADM is confined into ordered domains in the endothelial 
plasma membrane
Specific types of highly polarized epithelial cells express the MAL 
family members MAL and MAL2, which are involved in specialized, 
raft-dependent, apical vesicular trafficking (Puertollano et al., 1999; 
de Marco et al., 2002). MYADM, in contrast, is expressed ubiqui-
tously and organizes membrane rafts at the epithelial cell surface, 
thereby affecting cell spreading and motility (Aranda et al., 2011). 
The endothelium can be considered as a simple squamous epithe-
lium (Palade et al., 1979). Because ordered membrane domains 
have been shown to be central to endothelial barrier function and 
signaling (Muppidi et al., 2004; Heyraud et al., 2007; Chidlow and 
Sessa, 2010; Triantafilou et al., 2010), we wondered whether these 
MAL proteins are expressed and play a role in primary human en-
dothelial cells. Detergent-resistant membrane (DRM) fractions were 
isolated from confluent human umbilical vein endothelial cells 
(HUVECs) and blotted with antibodies against MAL, MAL2, and 
MYADM, together with a panel of cell lines used as positive and 
negative controls. Endogenous MYADM was clearly detected in 
DRM fractions from all the analyzed cell types, including HUVECs, 
consistent with the ubiquitous expression pattern previously re-
ported (Aranda et al., 2011). In contrast, MAL and MAL2 were de-
tected only in DRM fractions from epithelial PC3 and Madin-Darby 
canine kidney (MDCK) cells (Figure 1A). Quantitative PCR (qPCR) 
assays confirmed that expression of MAL and MAL2 was negligible 
in HUVECs (Figure 1B). Further analysis of MYADM fractionation in 
HUVECs showed that this protein is almost exclusively found in 
DRMs (Figure 1, C and D). The 2B12 monoclonal antibody (mAb), 
raised against human MYADM is not suitable for immunofluores-
cence analysis (Aranda et al., 2011). For the study of MYADM distri-
bution, MYADM-green fluorescent protein (GFP) was expressed in 
human endothelial cells and analyzed by confocal microscopy. 
MYADM-GFP also partitioned in DRMs, indicating that the GFP tag 
does not alter MYADM insertion in plasma membrane domains 
(Figure 1E). MYADM-GFP was localized at the plasma membrane 
and in cell–cell junctions in confluent endothelial cells, and this 
distribution overlapped with the staining for filamentous actin 
and junctional markers, such as vascular endothelial (VE)-cadherin 
(Figure 1F, insets). A partial colocalization of MYADM-GFP at cell–cell 
junctions was also found with platelet endothelial cell adhesion mole-
cule (PECAM)-1, p120-catenin, occludin, and nectin-2 (Supplemental 
Figure S1). In contrast, MYADM-GFP showed little colocalization with 
caveolin-1, a raft-associated protein essential for vascular homeosta-
sis (Chidlow and Sessa, 2010), or with CD59, a glycosylphosphati-
dylinositol (GPI)-anchored protein often used as a marker of mem-
brane rafts (Millán et al., 2006), which suggests that MYADM could 
organize ordered membrane domains differently from caveolae or 
CD59 in human endothelial cells (Figure 1F).
MYADM knockdown induces an inflammatory-like 
phenotype by inducing ICAM-1 expression
To gain insight into the role of MYADM in endothelial cells, we 
investigated the effects of three different small interfering RNAs 
(siRNAs) that targeted MYADM with low (siMYADM 1), medium 
picket fence that controls the stiffness of the cell surface and the abil-
ity of lipids and proteins to diffuse and signal (Ritchie et al., 2003). 
The 4.1 family proteins, ezrin, radixin, and moesin (ERM), are the 
best-known connectors between plasma membrane, transmem-
brane receptors, and the subcortical actin cytoskeleton (Bretscher 
et al., 2002; Viola and Gupta, 2007). An additional level of complex-
ity in cell surfaces arises from the fact that the complex mixture of 
lipids forming the plasma membrane does not distribute homoge-
neously but can form microdomains with specific subsets of proteins. 
The model that best explains this heterogeneity, although it is still 
under debate, posits the existence of liquid-ordered membrane do-
mains enriched in glyco lipids and cholesterol, termed membrane 
rafts. Raft-mediated plasma membrane condensation would regulate 
signaling, protein trafficking, and compartmentalization (Lingwood 
and Simons, 2010; Simons and Gerl, 2010).
Some evidence suggests a mutual regulation between ERM pro-
teins and ordered membrane rafts (Viola and Gupta, 2007). On acti-
vation, ERMs acquire an open conformation in which the N-terminal 
Four point one, ezrin, radixin-moesin (FERM) domain interacts di-
rectly or indirectly with the cytoplasmic tails of transmembrane recep-
tors, and the C-terminal domain binds to actin filaments (Fehon et al., 
2010). The FERM domain binds the raft lipid phosphatidylinositol 
4,5-bisphosphate (PIP2) and some transmembrane proteins that also 
partition into ordered membranes (Wojciak-Stothard et al., 1999; 
Tilghman and Hoover, 2002; Johnson et al., 2008; Kwiatkowska, 
2010). ERMs themselves have also been found compartmentalized 
into ordered membrane domains (Tomas et al., 2002; Gupta et al., 
2006; Heyraud et al., 2007). Finally, active ERMs have been shown to 
regulate membrane raft content (Prag et al., 2007) and prevent mem-
brane raft coalescence (Gupta et al., 2006).
Inflammatory cytokines have the ability to alter the endothelial 
barrier to cells and solutes by mechanisms that are not completely 
understood (Vandenbroucke et al., 2008). Disruption of cholesterol-
rich membrane rafts has been shown to either promote or ameliorate 
inflammation in different cell types (Legler et al., 2003; Flemming 
et al., 2004; Meng et al., 2010). In addition, cytokines such as tumor 
necrosis factor-α (TNF-α) and interleukin-1β (IL-1β) activate ERM pro-
teins. This activation mediates the increase in endothelial permeabil-
ity or the transcriptional regulation in response to TNF-α (Kishore 
et al., 2005; Koss et al., 2006). However, the full role of ERM activa-
tion in the endothelial inflammatory response is still not well defined. 
It is of note that ERM proteins play an important role localizing recep-
tors involved not only in leukocyte adhesion but also in the regulation 
of endothelial permeability in an inflammatory context, for example, 
intercellular adhesion molecule (ICAM)-1 or vascular cell adhesion 
molecule (VCAM)-1 (van Wetering et al., 2003; Clark et al., 2007; 
Sumagin et al., 2008).
In the current model of ordered membrane domains or rafts, pro-
tein machinery associated with these platforms is required to specify 
their function in the cell (Bauer and Pelkmans, 2006; Lingwood and 
Simons, 2010). The MAL family consists of integral proteins with sev-
eral transmembrane domains involved in membrane dynamics 
(Sanchez-Pulido et al., 2002). Several lines of evidence support a role 
for these proteins in events related to organization of membrane do-
mains, such as polarized membrane trafficking or plasma membrane 
reorganization in response to extracellular signaling (Puertollano 
et al., 1999; Anton et al., 2008; Goldstein Magal et al., 2009; Anton 
et al., 2011; Aranda et al., 2011). Myeloid-associated differentiation 
marker (MYADM) is a MAL family protein that regulates membrane 
order in migrating epithelial cells (Aranda et al., 2011). In this paper, 
we report that MYADM is a component of endothelial surface rafts. 
MYADM knockdown induces an inflammatory-like phenotype, 
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(siMYADM 2), and high efficiency (siMYADM 
3; Figure 2, A and B). MYADM silencing 
caused a clear disruption of the endothelial 
monolayer and partially disorganized cell–
cell junctions, as shown by staining of β-
catenin, VE-cadherin, or PECAM-1 (Figure 
2, C and D). MYADM reduction induced the 
appearance of intercellular gaps (Figure 2, 
C and D, asterisks, and E) and increased 
both filamentous (F)-actin (Figures 2, C and 
F, and S2) and permeability in Transwell as-
says (Figure 2G). Collectively these results 
indicate that MYADM knockdown caused 
endothelial barrier dysfunction.
Increased permeability and polymeriza-
tion of actin are prototypical endothelial 
responses to several inflammatory stimuli 
(Pober and Sessa, 2007). We tested 
whether MYADM knockdown was inducing 
an inflammatory-like response by following 
the expression of different receptors previ-
ously involved in leukocyte adhesion and 
permeability and considered typical inflam-
matory markers (Albelda, 1991; Clark et al., 
2007; Sumagin et al., 2008). Western blot 
analysis indicated that reduction of MYADM 
levels induced the expression of the adhe-
sion receptor ICAM-1, but not of E-selectin 
or VCAM-1 (Figure 3, A and B). MYADM 
knockdown also increased ICAM-1 mRNA, 
as shown by qPCR experiments (Figure 
3C). Immunofluorescence assays revealed 
the surface accumulation of this receptor in 
MYADM-depleted cells (Figure 3D). In con-
trast, no difference was found in the ex-
pression of different components of cell–
cell junctions involved in modulation of 
barrier function in an inflammatory context 
(Fernandez-Martin et al., 2012; Reglero-Real 
et al., 2012), such as VE-cadherin, β-catenin, 
p120-catenin, and PECAM-1 (Figure 3A). 
The Rho GTPases RhoA, Rac1, and Cdc42 
have been involved in permeability and 
F-actin regulation. No statistically significant 
changes were detected in their activity upon 
MYADM knockdown (Figure S3, A and B). 
Also, no significant alteration was detected 
in the phosphorylation of regulatory myosin 
FIGURE 1: MYADM is a transmembrane protein associated with endothelial DRMs. (A) The 
indicated cell types were extracted with 1% Triton X-100 at 4ºC and centrifuged to equilibrium 
in sucrose density gradients. Aliquots from DRMs were immunoblotted for MYADM, MAL2, 
human MAL (hMAL), canine MAL (dMAL), and caveolin-1 (Cav-1). (B) RNA from the indicated 
cells was isolated and the expression of MYADM, MAL2 and MAL transcripts was analyzed by 
qPCR. Results were normalized to mRNA levels of housekeeping genes (β-actin and GADPH) 
and represented as percentage of PC3 mRNA levels for MYADM and MAL2 transcripts (left) or 
Jurkat mRNA levels for the MAL transcript (right). (C) Aliquots from soluble (SOL) and DRM 
fractions from HUVECs were immunoblotted for MYADM, Cav-1 (as a control of endothelial 
DRMs), and transferrin receptor (TfR; as a control of transmembrane proteins in the soluble 
fraction). (D) Quantitation of DRM 
segregation of the indicated protein from 
three independent experiments. (E) DRMs 
were isolated from cells expressing MYADM-
GFP for 24 h and immunoblotted for MYADM 
with anti-MYADM mAb 2B12 and for 
caveolin-1. (F) MYADM-GFP distributes at the 
plasma membrane of HUVECs and partially 
colocalizes with subcortical F-actin and with 
VE-cadherin. Caveolin-1 and CD59 staining 
reveals little colocalization of MYADM-GFP 
with caveolae or with GPI-protein rich-rafts in 
endothelial cells. Scale bar: 20 μm.
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FIGURE 2: MYADM knockdown alters endothelial barrier function. (A) HUVECs were transfected in parallel with control 
siRNA (siControl) or with three different siRNAs targeting MYADM (siMYADM). At 72 h after transfection, MYADM 
levels were analyzed by immunoblotting. ERK-1/2 and caveolin-1 (Cav-1) levels are shown as loading controls. 
(B) Quantitation of MYADM reduction in response to siRNA transfection. The mean + SEM from three independent 
experiments is presented. (C and D) HUVECs were transfected with the indicated siRNAs and plated at confluence on 
fibronectin-coated coverslips. After 72 h, cells were fixed and stained for F-actin and β-catenin (C) or VE-cadherin or 
PECAM-1 (D) to detect cell–cell junctions. Asterisks in the images indicate intercellular gaps. Scale bar: 20 μm for (C) 
and 10 μm for (D). (E) Quantitation of intercellular gaps in cells transfected with the indicated siRNAs. (F) Cells were 
fixed and stained with antibody against total actin or with TRITC–phalloidin. Quantitation of the ratio F-actin/total actin 
(see Figure S2). (G) HUVECs were transfected with the indicated siRNAs and plated at confluence on Transwells, and 
permeability assays were performed 72 h after transfection. The mean + SEM from three independent experiments is 
shown. *, p < 0.05; **, p < 0.01.
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FIGURE 3: MYADM knockdown induces ICAM-1 expression. HUVECs were transfected with the indicated siRNAs for 
72 h, and the expression of different proteins involved in endothelial barrier function was analyzed by Western blot (A). 
Quantitation of ICAM-1 protein (B) and mRNA by qPCR (C). The mean + SEM from three (B) and two (C) independent 
experiments is shown. **, p < 0.01. (D) Localization of ICAM-1 in siRNA-transfected cells by immunofluorescence 
analysis. (E) HUVECs expressing MYADM-GFP for 36 h were stimulated with TNF-α (10 ng/ml) for 6 h to induce 
detectable levels of ICAM-1. Subsequently the receptor was cross-linked with specific antibodies (X-ICAM-1). Cells were 
fixed, permeabilized, and stained with TRITC–phalloidin to visualize F-actin. (F) HUVECs expressing MYADM-GFP were 
starved, stimulated with TNF-α (10 ng/ml) for 6 h to induce expression of adhesion receptors, and then incubated with 
T-cells for 15 min. Cells were fixed and stained with TRITC–phalloidin to visualize F-actin (top panels) or with TRITC–
phalloidin and anti–caveolin-1 antibody (bottom panels). T-cells adhering or transmigrating were morphologically 
distinguishable by the F-actin staining (red dotted line). Right graphs show intensity profiles across the T-cell–endothelial 
cell interaction area along the indicated white arrows.
488 | J. F. Aranda et al. Molecular Biology of the Cell
cells, whereas cells undergoing double silencing for MYADM and 
ICAM-1 restored endothelial barrier upon calcium replenishment, 
with dynamics comparable with control cells. In accordance, analysis 
of β-catenin staining showed that ICAM-1 reduction ameliorates the 
loss of cell–cell junction integrity in MYADM knockdown cells (Figure 
5, C and D). These experiments indicate that increased ICAM-1 ex-
pression mediates endothelial barrier reduction upon MYADM 
knockdown.
MYADM knockdown increases ERM phosphorylation
MYADM colocalizes with the cortical actin cytoskeleton and regu-
lates ordered membrane domains at the plasma membrane (Aranda 
et al., 2011). We hypothesized that MYADM controls the inflamma-
tory status by regulating proteins involved in plasma membrane 
and/or cortical actin organization of endothelial cells (Viola and 
Gupta, 2007). Activation of ERM proteins, connectors between the 
plasma membrane and the cytoskeleton, increases permeability in 
microvascular endothelial cells during the inflammatory response 
(Koss et al., 2006), so we tested the effect of MYADM knockdown on 
ERM phosphorylation at a specific threonine residue that is required 
for their conformational change and subsequent activation. Western 
blotting with an antibody recognizing phosphorylated ezrin (T567), 
radixin (T564), and moesin (T558) revealed that MYADM silencing 
increased ERM phosphorylation two- to threefold (Figure 6, A and 
B). Confocal analysis of MYADM-depleted cells confirmed an in-
crease in phosphorylated ERMs at the plasma membrane (Figure 
6C). Both in control and MYADM-depleted cells, pERM appeared 
particularly enriched in junctional membrane projections, often con-
necting two adjacent cells. The length of these border protrusions 
increased in response to MYADM knockdown (Figure 6C, arrow-
heads, and D). We then examined whether ERM phosphorylation 
can contribute to endothelial barrier dysfunction. Transfection of a 
constitutive active form of ERMs (moesin T558D) caused a moder-
ate decrease of cell–cell junction integrity, whereas moesin T558A 
mutant, which is proposed to be in a closed, inactive conformation, 
did not significantly alter the distribution of the junctional marker 
β-catenin (Figure 6, E and F).
ICAM-1 expression increases in response to MYADM 
reduction or TNF-α requires ERM expression
We then examined whether ERM proteins mediate ICAM-1 protein 
increase caused by MYADM knockdown. Cells were transfected with 
control siRNA or siRNA targeting MYADM (siMYADM 2), ERM pro-
teins (siE+R+M), or both (Figures 7A and S5, A and B). MYADM single 
knockdown increased ICAM-1, whereas simultaneous silencing of 
MYADM and ERM proteins reduced ICAM-1 to control levels (Figure 
7, A and B). In MYADM-depleted cells, single knockdown of ezrin, 
radixin, and moesin reduced ICAM-1 expression to a lesser extent 
than simultaneous triple-ERM silencing (Figure S5C). These findings 
indicate that the three proteins are playing additive roles. Accord-
ingly, ERM knockdown diminished the increase in leukocyte adhe-
sion caused by MYADM depletion (Figure 7C). Triple-ERM knock-
down diminished barrier integrity in control cells, due probably to the 
essential role of these cross-linker proteins in connecting membrane 
to subcortical cytoskeleton, so no rescue of function could be per-
formed following this strategy. Together our data indicate that 
MYADM reduction induces a proinflammatory-like phenotype by 
regulating ERM protein phosphorylation and ICAM-1 expression. 
Several protein kinases can potentially regulate ERM phosphoryla-
tion in this particular threonine residue. Among them, classical protein 
kinase C (PKC) family members, serine/threonine kinases that require 
a proper translocation from the cytosol to the plasma membrane and 
light chain, which indicates that actomyosin-mediated contractility 
downstream of RhoA is not affected by MYADM depletion (Figure 
S3C). Although MYADM knockdown induces intercellular gaps, no 
increase in VE-cadherin tyrosine phosphorylation or decrease in β-
catenin association to VE-cadherin was detected upon MYADM 
knockdown (Figure S4), which suggests the stability of adherens 
junctions is not regulated by MYADM expression. Collectively these 
experiments indicate that MYADM plays a role in barrier function 
and ICAM-1 transcriptional regulation.
MYADM did not appear to associate with ICAM-1, in either 
ICAM-1 immunoprecipitation (unpublished data) or cross-linking ex-
periments (Figure 3E). In addition, MYADM did not distribute around 
either adhered or transmigrating leukocytes (Figure 3F), in contrast 
with caveolin-1, which is enriched in areas where T-cells are transmi-
grating transcellularly, as previously described (Carman and Springer, 
2004; Millán et al., 2006; Keuschnigg et al., 2009). Altogether these 
data suggest that MYADM depletion induces an increase in ICAM-1 
expression but that MYADM is not directly associated with ICAM-1 
or involved in ICAM-1 function. To rule out the possibility of an off-
target effect of the siRNA oligonucleotides, we followed a rescue-
of-function strategy by transfecting siMYADM 2, which targets the 3′ 
untranslated region of MYADM mRNA, in wild-type HeLa cells or in 
HeLa cells stably expressing MYADM-GFP (Aranda et al., 2011). The 
MYADM-GFP transcript lacks the 3′ untranslated region and is thus 
resistant to siMYADM 2–mediated knockdown. siMYADM 2 trans-
fection induced ICAM-1 expression only in parental HeLa cells, 
whereas, as predicted, no changes were observed in cells stably 
expressing MYADM-GFP (Figure 4).
MYADM controls endothelial barrier function and ICAM-1 ex-
pression. We next addressed whether alteration of endothelial bar-
rier function in MYADM knockdown (KD) cells is a consequence of 
such receptor increase. HUVECs were transfected with control 
siRNA, siRNA targeting either MYADM (siMYADM 2) or ICAM-1, or 
both simultaneously (Figure 5A), and subjected to calcium-switch 
experiments in an ECIS platform in order to analyze barrier dynamics 
(Figure 5B). Barrier formation was impaired in MYADM knockdown 
FIGURE 4: Exogenous expression of MYADM prevents ICAM-1 
increase in response to MYADM siRNA transfection. (A) Parental HeLa 
cells or HeLa cells stably expressing MYADM-GFP were transfected 
with siControl or siMYADM 2 for 48 h. Cell extracts were then 
immunoblotted with anti–ICAM-1, anti-GFP, anti-MYADM, and 
anti–caveolin-1 (Cav-1) antibodies. (B) Quantitation of ICAM-1 levels in 
HeLa and HeLa-MYADM-GFP transfected with the indicated siRNAs. 
The mean + SEM is shown.
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response to this cytokine (Figure 7, I and J), and TNF-α did not 
significantly alter MYADM levels (Figure S6). Therefore these results 
indicate that ERM also regulates ICAM-1 expression in response to 
physiological inflammatory signaling. Collectively our data suggest 
that a connection between endothelial membrane and cortical actin 
cytoskeleton modulates the inflammatory response.
DISCUSSION
Membrane rafts are cholesterol-enriched ordered domains that reg-
ulate a plethora of signaling pathways. Cytokines such as TNF-α 
(Muppidi et al., 2004) and IL-1β (Oakley et al., 2009) or bacterial li-
gands of Toll-like-receptors (Soong et al., 2004; Triantafilou et al., 
2010) induce proinflammatory signals through membrane rafts. 
Moreover, modulation of cholesterol content in these domains can 
induce or decrease inflammatory signaling in different cell models 
(Legler et al., 2003; Flemming et al., 2004; Meng et al., 2010). 
Collectively these observations suggest that modulation of 
membrane condensation may itself contribute to the endothelial 
inflammatory response, probably by mimicking those changes in 
control endothelial barrier function (Hempel et al., 1997), have been 
shown to phosphorylate ERM proteins in different cellular contexts 
(Ng et al., 2001; Ivetic and Ridley, 2004; Adyshev et al., 2011). We 
addressed whether increased ERM phosphorylation in response to 
MYADM reduction is dependent on PKC by using a specific inhibitor 
for this family of kinases. Incubation with Gö6976 for 8 h partially re-
duced ERM phosphorylation increase in MYADM siRNA–transfected 
cells, which suggests that MYADM is involved in regulating classical 
PKC-mediated activation of ERM proteins at the plasma membrane 
(Figure 7D). Together these results are compatible with a role for 
MYADM organizing endothelial plasma membrane and thereby reg-
ulating the membrane targeting of proteins, such as classical PKCs, 
that control subcortical protein machinery. Finally, we investigated 
whether ERM can also regulate ICAM-1 expression in a more physi-
ological context. TNF-α is a proinflammatory cytokine that induces 
ICAM-1 expression and ERM phosphorylation (Koss et al., 2006; 
Figure 7, E and F). Triple-ERM knockdown reduced ICAM-1 
increment upon TNF-α exposure (Figure 7, G and H). In contrast, 
MYADM knockdown did not exacerbate ICAM-1 increase in 
FIGURE 5: ICAM-1 knockdown prevents alteration of endothelial barrier function in response to MYADM reduction. 
HUVECs were transfected with the indicated siRNAs for 72 h. (A) Western blot analysis of ICAM-1 expression. ERK 1/2 
is shown as a loading control. (B) Dynamics of barrier function in siRNA-transfected cells. Normalized transendothelial 
electrical resistance (TEER) of cells subjected to calcium switch in order to observe barrier formation. Right, quantitation 
of normalized resistance 60 min after calcium switch. The mean + SEM of three independent experiments with duplicate 
readings is shown. **, p > 0.02. (C) Cells were fixed and stained with β-catenin– and ICAM-1–specific antibodies. 
Asterisks in images indicate intercellular gaps. (D) Quantitation of intercellular gaps found in siRNA-transfected cells. 
Thirty images containing around 30 cells each were quantitated. The mean + SEM is shown. *, p < 0.05.
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clustering or diffusion that different stimuli 
can induce on protein signaling machinery 
associated with the plasma membrane. This 
could be important for chronic inflammatory 
diseases such as arteriosclerosis, which is 
triggered by deregulation of homeostasis of 
raft lipids, as is seen in hypercholesterolemia 
(Libby, 2002). However, ordered membrane 
microdomains require protein scaffolds to 
play specific roles within the cell (Bauer and 
Pelkmans, 2006). The MAL proteins contain 
one or two tetra-spanning MARVEL (MAL 
and related proteins for vesicle trafficking 
and membrane link) domains that are in-
volved in membrane apposition (Sanchez-
Pulido et al., 2002). Different experimental 
strategies have shown that these proteins 
have the ability to modulate membrane or-
der or dynamics in a variety of cell types 
(Puertollano et al., 1997; Goldstein Magal 
et al., 2009; Aranda et al., 2011). As a conse-
quence, these proteins control the segrega-
tion into membrane rafts of signaling pro-
teins, such as the tyrosine kinase Lck (Anton 
et al., 2008) or the Rho GTPase Rac-1 
(Aranda et al., 2011). In this paper, we show 
that, of the three MAL family proteins with a 
reported role in raft-mediated function, only 
MYADM is expressed in endothelial cells. 
MYADM is also the only member of the MAL 
family containing two MARVEL domains, 
rather than one. This feature seems to de-
termine its predominant localization at the 
plasma membrane, rather than in vesicular 
compartments (Aranda et al., 2011), al-
though MYADM trafficking has yet to be de-
fined. On the other hand, colocalization 
analysis clearly shows that MYADM-contain-
ing domains are different than those of cav-
eolae or GPI-anchored proteins in endothe-
lial cells, in agreement with our previous 
studies in other cell types or with other MAL 
family proteins (Millán et al., 1997; Aranda 
et al., 2011).
ERM proteins are cross-linkers between 
transmembrane receptors and cortical actin 
filaments that regulate the structure and func-
tion of specific domains at the cell surface, 
namely microvilli or filopodia, and fundamen-
tal signaling processes involved in cell shape, 
junctional stability, motility, and cytokinesis 
(Fehon et al., 2010). Cytokines, such as IL-1β 
FIGURE 6: MYADM knockdown activates ERM proteins. (A) HUVECs were transfected with the 
indicated siRNAs for 72 h, and ERM activation was monitored by Western blot with anti-
pE(T567)R(T564)M(T558)–specific antibody (pERM) and anti-ERM protein antibody. 
(B) Quantitation of pERM activation was performed by measuring the ratio of anti-pERM 
to ERM blotting signal. The mean + SEM from three independent experiments is shown. 
(C and D) HUVECs were transfected as in (A) and fixed with 10% trichloroacetic acid, 
and pERM distribution was analyzed by immunofluorescence. Arrowheads indicate the 
pERM-rich protrusions (C), with their lengths quantitated in (D). (E) The HA-tagged moesin 
mutants, moesin T558A (TA), in an inactive conformation, or moesin T558D (TD), constitutively 
active, were transiently expressed in HUVECs for 48 h. Cells were fixed and stained with anti-HA 
and anti–β-catenin antibodies to detect 
transfected cells and cell–cell junctions, 
respectively. (F) Quantitation of β-catenin 
intensity of transfected cells normalized 
to the intensity of adjacent cells (control). 
Five hundred thirty regions from 53 
transfected cells were analyzed in three 
different experiments. The mean + SEM is 
shown. *, p < 0.05.
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FIGURE 7: ERM knockdown prevents ICAM-1 induction mediated by MYADM knockdown or TNF-α. (A) HUVECs were 
transfected with the indicated siRNAs for 72 h, and MYADM, ERM, and ICAM-1 expression was analyzed by Western 
blotting. (B) Quantitation of ICAM-1 levels in siRNA-transfected cells. (C) siRNA-transfected HUVECs were plated at 
confluence, and adhesion assays were performed 72 h after transfection. The mean + SEM from three independent 
experiments is shown. (D) HUVECs were transfected with the indicated siRNAs for 72 h. Eight hours before lysis, cells 
were incubated or not with 100 nm of the PKC inhibitor Gö6976. Subsequently MYADM, ERM, and ICAM-1 expression 
was analyzed by Western blotting. (E and F) HUVECs were stimulated at different times with TNF-α, lysed, and 
immunoblotted for the indicated antibodies. (G–J) siRNA-transfected HUVECs were stimulated at different times with 
TNF-α, lysed, and immunoblotted for the indicated antibodies. Graphs show the mean ± SEM from three independent 
experiments (H and J). *, p < 0.05; **, p < 0.01.
492 | J. F. Aranda et al. Molecular Biology of the Cell
MYADM knockdown regulates pathways related to cell stiffness and 
mechanotransduction. Finally, further understanding of the structure 
of membrane ordered domains, their protein machinery, and their 
involvement in inflammatory signaling could lead to the design of 
new therapies for chronic inflammatory diseases.
MATERIALS AND METHODS
Materials
Monoclonal antibody to human MYADM (mAb 2B12) was generated 
as previously described (Aranda et al., 2011). Rabbit anti–ICAM-1, 
anti–caveolin-1 (N-20), and anti-ERK1/2 antibodies were obtained 
from Santa Cruz Biotechnology (Santa Cruz, CA). Mouse anti–ICAM-1 
antibody was from R&D Systems (Abingdon, UK). Mouse monoclonal 
anti–VE-cadherin antibody was from BD Biosciences (San Jose, CA). 
Rabbit anti–β-catenin and TRITC/FITC–phalloidin was from Sigma-
Aldrich (St. Louis, MO). Anti–transferrin receptor antibodies were 
purchased from Zymed (San Francisco, CA). Anti-ERM, anti–phos-
pho-ERM, and specific anti-ezrin, anti-radixin, and anti-moesin anti-
bodies were from Cell Signaling Technology (Boston, MA). Hemag-
glutinin (HA)-tagged moesin-TD (T558D) and moesin-TA (T558A) 
were from J. Dêlon (Université René Descartes, Paris, France).
Cell culture and transfection
HUVECs were obtained and cultured as previously described (Millán 
et al., 2010) and were always plated at confluency on fibronectin-
coated dishes for 24–72 h. HeLa, MDCK, and PC3 cells were 
obtained from the American Type Culture Collection (Manassas, VA) 
and grown in DMEM supplemented with 5% fetal bovine serum. 
Isolation of HeLa clones stably expressing MYADM-GFP and human 
memory T-cells for adhesion assays has been described elsewhere 
(Millán et al., 2006; Aranda et al., 2011). HUVECs were transiently 
transfected with 1–5 μg plasmid DNA/106 cells with calcium phos-
phate and used for experiments 24–72 h after transfection. For 
siRNA transfection, we devised a protocol for delivery of siRNA with 
high efficiency into primary endothelial cells that is a modification 
of our previous method (Millán et al., 2006). HUVECs were plated 
at subconfluence (105 cells on each well of a six-well dish) in 
EBM-2 medium (Lonza, Walkersville, MD) with no antibiotics. The 
following day, cells were transfected by mixing 4 μl of oligofectamine 
(Invitrogen, Carlsbad, CA) with siRNA to a final concentration of 
100 nM. At 24 h after transfection, cells were trypsinized and plated 
at confluence onto different dishes for parallel assays, such as per-
meability, adhesion, immunofluorescence, or Western blotting. As-
says were performed 72 h after transfection. Sequences of siRNA 
duplexes targeting MYADM were 5′-CGAGATCACTGGCTATATG-3′ 
(siMYADM 1), 5′-GATGTAAGCTGCAGCCGCA-3′ (siMYADM 2), and 
5′GGTCTAAGACTCTCCCAAG-3′ (siMYADM 3). Ezrin was targeted 
with the siRNA oligonucleotide 5′-CAAGAAGGCACCUGACUUU-3′, 
moesin with 5′-AUAAGGAAGUGCAUAAGUC-3′, and radixin with 
5′-GAACUGGCAUGAAGAACAU-3′. Sequences of siRNA controls 
were obtained from Dharmacon (Lafayette, CO)
DRM isolation
Different cell lines and HUVECs grown to confluence in 100-mm 
dishes were lysed for 20 min in 1 ml of 25 mM Tris-HCl (pH 7.5), 
150 mM NaCl, 5 mM EDTA, 1% Triton X-100, 4°C, as indicated 
(Millán et al., 2002). DRM fraction was isolated by centrifugation to 
equilibrium in a sucrose discontinuous density gradient in a swing-
ing bucket SW40 rotor (Beckman Coulter, Brea, CA) at 39,000 rpm 
(188,000 × g) for 20 h (Brown and Rose, 1992; Millán et al., 2006). 
Fractions were harvested from the bottom sucrose layer (40%; solu-
ble) and from the above interphase between 5 and 30% sucrose 
and TNF-α, or sphingosine 1-phosphate (S1P), all of which are in-
volved in the regulation of the inflammatory response, can also acti-
vate ERM proteins (Koss et al., 2006; Adyshev et al., 2011; Huang 
et al., 2011). This activation, at least for TNF-α and S1P, mediates 
changes in endothelial barrier function, with different outcomes de-
pending on the stimulus. Ordered domains at the plasma membrane 
and ERM proteins have thus been independently implicated in inflam-
mation. In this study, we demonstrate that siRNA-mediated modula-
tion of MYADM is sufficient to induce activation of ERM proteins, and 
this can act as a signal to alter barrier function and to provoke an in-
flammatory-like response in the absence of inflammatory stimuli. As 
the immunofluorescence analysis indicates, ERM activation occurs at 
the plasma membrane and at cell borders. A previous example of 
cross-regulation between rafts and ERM proteins at the plasma mem-
brane has been reported in B-cells, in which ezrin can modulate the 
dynamics of ordered domains and their ability to contribute to B-cell 
receptor (BCR) signaling (Gupta et al., 2006; Viola and Gupta, 2007). 
Gupta et al. (2006) proposed that, in resting B-cells, active ezrin main-
tains small raft domains that contain signaling molecules and are 
linked to cortical F-actin and dispersed on the cell surface. On BCR 
activation, ezrin becomes transiently inactivated and uncouples actin 
from the plasma membrane domains. These small rafts then coalesce 
and promote downstream B-cell signaling. It is therefore plausible 
that membrane rafts, which are regulated by MYADM, in coordination 
with the ERM proteins, which connect rafts to the subcortical cytoskel-
eton, could mediate clustering, diffusion or localization of proteins 
involved in signaling from inflammatory agonists in endothelial or epi-
thelial cells. In accordance, we have found that, at least for TNF-α, a 
complete inflammatory response requires ERM protein expression. 
MYADM was not modulated by TNF-α, and its reduction had no ef-
fect on TNF-α–mediated ICAM-1 induction. The identification of the 
stimuli that act through MYADM and ERM proteins to promote or in-
hibit inflammation will be important to increase our understanding of 
the endothelial inflammatory response.
ERMs are involved in the inflammatory control of protein expres-
sion (Kishore et al., 2005) and in connecting adhesion receptors, such 
as the ICAM family, to subcortical actin (Viola and Gupta, 2007; 
Reglero-Real et al., 2012). In this paper, we show that ERM expression 
is required for ICAM-1 expression in response to MYADM suppres-
sion or TNF-α. ICAM-1 is a paradigmatic adhesion receptor that regu-
lates leukocyte adhesion. However, its role as a protein essential for 
controlling endothelial permeability both in vivo and in vitro is emerg-
ing (Clark et al., 2007; Sumagin et al., 2008). MYADM knockdown 
selectively increases ICAM-1 expression, but not many other proteins 
involved in barrier function, which indicates this protein selectively 
controls some but not all of the pathways involved in the endothelial 
inflammatory response. ICAM-1 increase is necessary for MYADM-
mediated alteration of barrier properties, which is in agreement with 
previous reports that link leukocyte adhesion and permeability 
through dual roles played by ICAM-1 (Clark et al., 2007; Sumagin 
et al., 2008), VCAM-1 (van Wetering et al., 2003), or PECAM-1 
(Graesser et al., 2002; Fernandez-Martin et al., 2012) receptors.
Regulation of the interaction between the plasma membrane 
and the underlying cytoskeleton is also essential in mechanotrans-
duction (Chien, 2007). Cholesterol-rich membrane domains are re-
quired for signaling propagated by mechanic forces induced by 
shear stress (Yamamoto et al., 2003) or stretch (Zeidan et al., 2003). 
Laminar shear stress elicits proinflammatory signals that promote 
ICAM-1 up-regulation in vitro (Tzima et al., 2002). Pathological 
alteration of these forces in vivo, such as disturbed blood flow, are 
proinflammatory and proatherogenic (Chien, 2007). It is therefore 
possible that membrane and actin reorganization induced by 
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qPCR analysis
One microgram of RNA from HUVECs, PC3, Jurkat, and HepG2 
cell lines was subjected to reverse transcription with the High 
Capacity RNA-cDNA kit (Applied Biosystems, Bedford, MA). qPCR 
was performed from the resulting cDNA in a thermocycler CFX 384 
(Bio-Rad, Hercules, CA) using the SsoFast EvaGreen Supermix 
(Bio-Rad) and the following forward and reverse primers, previ-
ously designed with Probefinder software (Roche Diagnostics, 
Indianapolis, IN): MAL2, 5′-GACATCCTGCGGACCTACTC-3′; 
5′-AGACAAGACCCCCGAACAG-3′. MYADM, 5′-GCCATCTGCT-
TCATCCTAGC-3′; 5′-TAGCACGTTGGTGCACTCC-3′. MAL, 5′-AG-
ACTTCCTGGGTCACCTTG-3′; 5′-CGTCTTGCATCGTGATGGT-3′. 
Parallel qPCR from β-actin and GADPH was performed to 
normalize data from each cell type with the following primers: β-
actin, 5′-CAGGCACCAGGGCGTG-3′; 5′-GTGAGGATGCCTCTCT-
TGCTCT-3′. GADPH, 5′-AGCCACATCGCTCAGACAC-3′; 5′-CG-
CCCAATACGACCAAAT-3′.
layers (DRMs). Equivalent aliquots were subjected to immunoblot 
analysis with the appropriate antibodies.
ICAM-1 cross-linking and immunofluorescence
Anti–ICAM-1 antibody (1 μg/ml) was added to TNF-α–stimulated 
HUVECs for 45 min. Cells were rinsed and incubated with 1 μg/ml of 
fluorophore-coupled secondary antibody for 30 min to induce re-
ceptor clustering. Cells were rinsed and fixed with 4% paraformal-
dehyde for 20 min, blocked with TBS (25 mM Tris, pH 7.4, 150 mM 
NaCl) for 10 min, permeabilized for 5 min with phosphate-buffered 
saline (PBS) containing 0.2% Triton X-100 at 4°C, and incubated at 
37°C with tetramethylrhodamine isothiocyanate (TRITC)-labeled 
phalloidin to visualize F-actin. Specimens were mounted in DAKO 
fluorescent mounting medium (DAKO, Ely, UK). For immunofluores-
cence analysis of adhered T-cells, unlabeled T-cells were added to 
transfected HUVECs stimulated with TNF-α for 6 h. Cells were fixed 
and stained with the indicated antibodies and with TRITC–phalloidin 
to visualize T-cells. For F-actin quantification, confocal images from 
cells stained for TRITC-labeled phalloidin were exported in formats 
compatible with ImageJ software (http://rsb.info.nih.gov/ij). ImageJ 
was used to obtain the mean fluorescence intensities from different 
images of confluent cells.
Adhesion assays
Starved memory T-cells were labeled with 2′,7′,-bis-(2-carboxyethyl)-
5-(and-6)-carboxyfluorescein, acetoxymethyl ester (Molecular 
Probes, Eugene, OR) in serum-free medium for 20 min, washed with 
medium containing 1% BSA, and incubated for 15 min at 37°C 
with confluent HUVECs previously transfected with different siRNAs. 
Nonadhered cells were washed off, and adhesion was determined 
by fluorescence measurement in a Fusion α-FS fluorimeter (Perkin 
Elmer-Cetus, Waltham, MA). Data were processed and statistical 
significance was determined using Student’s t test (Microsoft 
Excel; Redmond, WA). For immunofluorescence analysis of adhered 
T-cells, unlabeled T-cells were added to transfected HUVECs stimu-
lated with TNF-α for 6 h. Cells were fixed and stained with TRITC–
phalloidin (to visualize T-cells) and with the indicated antibodies.
Permeability assays
Permeability assays were carried out as previously described 
(McKenzie and Ridley, 2007). siRNA-transfected HUVECs were 
plated at confluence on fibronectin-coated Transwells of 0.4-μm 
diameter. FITC-dextran (Mr 42,000; Sigma–Aldrich) was applied 
apically at 0.1 mg/ml and allowed to equilibrate for 60 min before a 
sample of the medium was removed from the lower chamber to 
measure fluorescence in the Fusion α-FS fluorimeter. The arithmetic 
mean, SE, and statistical significance corresponding to a Student’s t 
test were calculated in Microsoft Excel. Alternatively, real-time per-
meability assays were performed using an electric cell-substrate im-
pedance sensing system (ECIS 1600R; Applied Biophysics, Troy, NY) 
as previously described (Fernandez-Martin et al., 2012). Briefly, 
2 × 105 cells/cm2, previously transfected with the indicated siRNA 
oligonucleotides, were plated in a well precoated with fibronectin 
(200 mg/ml) and containing 10 small-fold electrodes and a counter-
electrode (8W10E arrays; IBIDI, Martinsried, Germany). After 48 h at 
confluency, transendothelial electrical resistance (TEER) was mea-
sured in each well (4000-Hz frequency). The TEER analysis included 
basal measurements during the first 2 to 4 h, followed by a calcium-
switch assay in which cells were incubated in PBS for 20 min and the 
calcium levels were subsequently restored by replenishment with 
normal EBM-2 medium. Data were normalized to the mean resis-
tance detected before the calcium switch.
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